FINWIRES · TerminalLIVE
FINWIRES

IBEX Board Approves up to $20 million Stock Buyback Plan

By

IBEX (IBEX) said Wednesday its board approved a share buyback plan of up to $20 million over the next 12 months.

The company said purchases may be made through open-market transactions, privately negotiated deals, block trades, or other methods permitted under securities rules.

IBEX said it plans to fund the repurchases with cash on hand and free cash flow.

Price: $31.40, Change: $+0.38, Percent Change: +1.23%

Related Articles

Australia

Wedbush Lifts Price Target on Alto Neuroscience to $24 From $21, Maintains Neutral Rating

Alto Neuroscience (ANRO) has an average rating of buy and mean price target of $35.52, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $23.62, Change: $-1.01, Percent Change: -4.10%

$ANRO
Australia

Algoma Steel Group Maintained at Buy at Stifel Canada Following Q1 Results; Price Target Kept at C$11.50

Stifel Canada on Wednesday maintained its buy rating on the shares of Algoma Steel Group (ASTL.TO) and its C$11.50 price target after the company released first-quarter results."Algoma's 2Q26 adj. EBITDA (prior to capacity utilization adjustments) of -$111 mm was modestly better than our forecast of -$122 mm. Importantly, net debt exiting 1Q26 was $892 mm, 7.2% below our estimate of $961 mm. Liquidity exiting the quarter was $553 mm, and our FCF forecast between 2Q26E and 4Q26E is $13 mm due to a large tax refund expected in 3Q26E. We continue to believe the company has ample liquidity to last through the next Federal Election in the U.S. (potential tariff relief), and to retain its status as a "champion" that will benefit from Canadian defense spending," analyst Ian Gillies wrote.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $7.36, Change: $+0.50, Percent Change: +7.29%

$ASTL.TO
Australia

Affirm Makes 'Strong Case' for Updated Medium-Term Growth Targets, RBC Says

Affirm (AFRM) presented a "strong case" for achieving its updated "medium-term growth targets," driven by merchant point-of-sale financing, direct-to-consumer expansion and international growth, RBC Capital Markets said in a note Wednesday.The company is targeting $100 billion in gross merchandise volume, up from about $46 billion currently, while also forecasting stronger revenue margins and annual GAAP earnings per share of about $3 to $4. It also highlighted the Affirm "Card," enterprise merchant expansion and international partnerships as "key growth drivers," according to the note.Affirm's funding model is becoming a "competitive advantage" as the company scales, lowering funding costs through its network of about 200 "unique funding partners." A pending industrial bank charter could further strengthen the company's funding capabilities through deposits and loan origination, RBC said.RBC also pointed to "emerging opportunities" in agentic commerce and Affirm Edge, which embeds buy now, pay later services into banking apps through partnerships with "large commerce" companies.RBC has a sector perform rating on Affirm, with a price target of $80.Price: $63.78, Change: $-1.65, Percent Change: -2.52%

$AFRM